Respiratory Metagenomics Expansion Programme

{
  "awards": [
    {
      "aboveThreshold": true,
      "contractPeriod": {
        "endDate": "2028-12-08T23:59:59Z",
        "startDate": "2025-12-20T00:00:00Z"
      },
      "documents": [
        {
          "datePublished": "2025-12-19T15:45:13Z",
          "description": "Transparency notice on Find a Tender",
          "documentType": "awardNotice",
          "format": "text/html",
          "id": "085053-2025",
          "noticeType": "UK5",
          "url": "https://www.find-tender.service.gov.uk/Notice/085053-2025"
        }
      ],
      "hasOptions": true,
      "id": "1",
      "items": [
        {
          "additionalClassifications": [
            {
              "description": "Research laboratory services",
              "id": "73111000",
              "scheme": "CPV"
            }
          ],
          "id": "1",
          "relatedLot": "1"
        }
      ],
      "mainProcurementCategory": "services",
      "milestones": [
        {
          "dueDate": "2025-12-19T23:59:59Z",
          "id": "1",
          "status": "scheduled",
          "type": "futureSignatureDate"
        }
      ],
      "options": {
        "description": "The Term of this Contract shall expire on the 10th November 2028, unless otherwise extended by agreement in writing by both Parties."
      },
      "relatedLots": [
        "1"
      ],
      "status": "pending",
      "suppliers": [
        {
          "id": "GB-COH-05386273",
          "name": "Oxford Nanopore Technologies PLC"
        }
      ],
      "title": "Respiratory Metagenomics Expansion Programme",
      "value": {
        "amount": 7010966.0,
        "amountGross": 8413159.0,
        "currency": "GBP"
      }
    }
  ],
  "buyer": {
    "id": "GB-PPON-PDZC-6438-DGPX",
    "name": "Guy\u0027s and St Thomas\u0027 NHS Foundation Trust"
  },
  "date": "2025-12-19T15:45:13Z",
  "id": "085053-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-05faba",
  "parties": [
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "London",
        "postalCode": "SE1 9RT",
        "region": "UKI44",
        "streetAddress": "Great Maze Pond"
      },
      "contactPoint": {
        "email": "miranda.gordon@nhs.net",
        "name": "Miranda Gordon",
        "telephone": "020718885331"
      },
      "details": {
        "classifications": [
          {
            "description": "Public authority - central government",
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE"
          }
        ],
        "url": "https://www.guysandstthomas.nhs.uk"
      },
      "id": "GB-PPON-PDZC-6438-DGPX",
      "identifier": {
        "id": "PDZC-6438-DGPX",
        "scheme": "GB-PPON"
      },
      "name": "Guy\u0027s and St Thomas\u0027 NHS Foundation Trust",
      "roles": [
        "buyer"
      ]
    },
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "Oxford",
        "postalCode": "OX4 4DQ",
        "region": "UKJ14",
        "streetAddress": "Edmund Halley Road"
      },
      "contactPoint": {
        "email": "info@nanoporetech.com"
      },
      "details": {
        "scale": "large",
        "vcse": false
      },
      "id": "GB-COH-05386273",
      "identifier": {
        "id": "05386273",
        "scheme": "GB-COH"
      },
      "name": "Oxford Nanopore Technologies PLC",
      "roles": [
        "supplier"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "description": "GSTT will lead the development of a national clinical metagenomics pilot service by deploying NHS developed laboratory, bioinformatic and clinical protocols along with Oxford Nanopore developed sequencing technology to a network of 30 NHS sites across the UK for the dual benefit of patient care and bio-surveillance.",
    "documents": [
      {
        "description": "Not published",
        "documentType": "conflictOfInterest",
        "id": "conflictOfInterest"
      }
    ],
    "id": "C395947",
    "legalBasis": {
      "id": "2023/54",
      "scheme": "UKPGA",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
    },
    "lots": [
      {
        "id": "1",
        "status": "complete"
      }
    ],
    "procurementMethod": "direct",
    "procurementMethodDetails": "Direct award",
    "procurementMethodRationale": "In accordance with Section 41 and Schedule 5 of the PA23, this direct award is to be made on the grounds of absence of competition for technical reasons as the products and services are subject to patented technology by Oxford Nanpore Technologies PLC. It is unique in that it is the only sequencing technology available on the market that enables direct, real-time analysis of short to ultra-long fragments of DNA/RNA, in fully scalable formats. No other provider is able to supply equivalent goods or services.\nAdditional Information \u2013 The contracting authority has concluded that the conditions for a direct award are satisfied due to their being no alternatives and an absence of competition due to patent status of the required products and services. A Contract Award Notice (UK6) will be published following the expiry of the standstill period.",
    "procurementMethodRationaleClassifications": [
      {
        "id": "singleSuppliersIntellectualPropertyExclusiveRights"
      }
    ],
    "status": "complete",
    "title": "Respiratory Metagenomics Expansion Programme"
  }
}